Sue Catling
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sue Catling has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
C. Davies
Service Manager Cellular Pathology
1 shared publication- Catherine A. Thornton
Institute of Life Science, Swansea University Medical School, Swansea, Wales, UK
1 shared publication Euan Kevelighan
Consultant in Obstetrics and Gynaecology Singleton Hospital , Sketty Swansea SA2 8QA , UK
1 shared publicationHuda Al-Foudri
StR in Anaesthesia Singleton Hospital , Sketty Swansea SA2 8QA , UK
1 shared publicationI. T. Russell
Institute of Life Science, College of Medicine, Swansea University, Swansea, UK
1 shared publicationL. Hopkins
Assistant Service Manager Immunohistochemistry, Singleton Hospital, Swansea, SA8 2QA, UK
1 shared publication
Latest Publications
- 29 April 2015
- Published by Wiley in Anaesthesia
- Vol. 70 (9) , 1066-1072
Bradykinin and cysteinyl leukotriene concentrations in cell‐salvaged blood before and after passage through negatively charged filters during clinical use in cancer patients: a pilot study
Summary: It has been suggested that giving cell‐salvaged blood through a leucocyte depletion filter can cause hypotension due to bradykinin released when factor XII and platelets are activated by the negatively charged surface of the filter. We measured the concentration of bradykinin and cysteinyl leukotrienes in cell‐salvaged blood sampled before and after passage through a negatively charged leucodepletion filter in 24 consecutive patients with gynaecological or bowel cancer undergoing elective surgery with cell salvage. In no case was an increase in bradykinin concentration observed after passage through the filter; in 23 patients the post‐filtration bradykinin concentration was zero (p = 0.007). The change in the concentration of cysteinyl leukotrienes detected during passage across the filter was not statistically significant (p = 0.1). Our findings do not support the suggestion that either bradykinin or cysteinyl leukotrienes are generated in cell‐salvaged blood during passage through leucodepletion filters.
- 29 April 2015
- Published by Wiley in Anaesthesia
- Vol. 70 (9) , 1066-1072
Bradykinin and cysteinyl leukotriene concentrations in cell‐salvaged blood before and after passage through negatively charged filters during clinical use in cancer patients: a pilot study
Summary: It has been suggested that giving cell‐salvaged blood through a leucocyte depletion filter can cause hypotension due to bradykinin released when factor XII and platelets are activated by the negatively charged surface of the filter. We measured the concentration of bradykinin and cysteinyl leukotrienes in cell‐salvaged blood sampled before and after passage through a negatively charged leucodepletion filter in 24 consecutive patients with gynaecological or bowel cancer undergoing elective surgery with cell salvage. In no case was an increase in bradykinin concentration observed after passage through the filter; in 23 patients the post‐filtration bradykinin concentration was zero (p = 0.007). The change in the concentration of cysteinyl leukotrienes detected during passage across the filter was not statistically significant (p = 0.1). Our findings do not support the suggestion that either bradykinin or cysteinyl leukotrienes are generated in cell‐salvaged blood during passage through leucodepletion filters.
- Open Access
- 1 May 2011
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 106 (5) , 749
Coagulopathy during intraoperative cell salvage in a patient with major obstetric haemorrhage
Editor—Rudra and Basak1 are to be congratulated on their successful management of major obstetric haemorrhage in a patient with an atonic uterus. The latest CEMACH Report2 has highlighted atonic uterus as the commonest cause of fatal maternal haemorrhage.
- 1 May 2011
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 106 (5) , 749
Open AccessCoagulopathy during intraoperative cell salvage in a patient with major obstetric haemorrhage
Editor—Rudra and Basak1 are to be congratulated on their successful management of major obstetric haemorrhage in a patient with an atonic uterus. The latest CEMACH Report2 has highlighted atonic uterus as the commonest cause of fatal maternal haemorrhage.
- Open Access
- 15 April 2010
- Published by Elsevier in Continuing Education in Anaesthesia Critical Care & Pain
- Vol. 10 (3) , 81-87
CEMACH 2003–5 Saving Mothers' Lives: lessons for anaesthetists
The Confidential Enquiry into Maternal and Child Health (CEMACH) reviews every death in the UK occurring during pregnancy and up to 42 days post-partum. Originally titled Confidential Enquiries into Maternal Deaths (CEMD), this series of Reports is the longest running audit in the world. It covers every triennium since 1952, with sequential Reports having established the leading causes of maternal mortality and recommended change where appropriate. Up to 1985, only deaths in England and Wales were considered; thereafter, the whole UK was included.
- 15 April 2010
- Published by Elsevier in Continuing Education in Anaesthesia Critical Care & Pain
- Vol. 10 (3) , 81-87
Open AccessCEMACH 2003–5 Saving Mothers' Lives: lessons for anaesthetists
The Confidential Enquiry into Maternal and Child Health (CEMACH) reviews every death in the UK occurring during pregnancy and up to 42 days post-partum. Originally titled Confidential Enquiries into Maternal Deaths (CEMD), this series of Reports is the longest running audit in the world. It covers every triennium since 1952, with sequential Reports having established the leading causes of maternal mortality and recommended change where appropriate. Up to 1985, only deaths in England and Wales were considered; thereafter, the whole UK was included.
- 11 November 2008
- Published by Wiley in Anaesthesia
- Vol. 63 (12) , 1332-1338
Use of a leucocyte filter to remove tumour cells from intra‐operative cell salvage blood
Summary: The intra‐operative blood loss of 50 consecutive gynae‐oncology patients undergoing surgery for endometrial, cervical or ovarian cancer was cell salvaged and filtered. In each case blood samples were taken from the effluent tumour vein, a central venous line, the cell saver reservoir, the cell salvage re‐transfusion bag after processing but before filtration and from the cell salvage re‐transfusion bag after processing and filtration. Samples were examined using immunohistochemical monoclonal antibody markers for epithelial cell lines. Viable, nucleated malignant cells were detected in 2/50 central venous samples, 34/50 reservoir samples and 31/50 unfiltered cell salvaged samples. After passage through a Pall RS leucocyte depletion filter no remaining viable, nucleated malignant cells were detected in any sample. The clinical risks of cell salvage in these circumstances should be reviewed in the light of the risks of allogeneic blood transfusion.
- 11 November 2008
- Published by Wiley in Anaesthesia
- Vol. 63 (12) , 1332-1338
Use of a leucocyte filter to remove tumour cells from intra‐operative cell salvage blood
Summary: The intra‐operative blood loss of 50 consecutive gynae‐oncology patients undergoing surgery for endometrial, cervical or ovarian cancer was cell salvaged and filtered. In each case blood samples were taken from the effluent tumour vein, a central venous line, the cell saver reservoir, the cell salvage re‐transfusion bag after processing but before filtration and from the cell salvage re‐transfusion bag after processing and filtration. Samples were examined using immunohistochemical monoclonal antibody markers for epithelial cell lines. Viable, nucleated malignant cells were detected in 2/50 central venous samples, 34/50 reservoir samples and 31/50 unfiltered cell salvaged samples. After passage through a Pall RS leucocyte depletion filter no remaining viable, nucleated malignant cells were detected in any sample. The clinical risks of cell salvage in these circumstances should be reviewed in the light of the risks of allogeneic blood transfusion.
- 1 January 2008
- Published by SAGE Publications in Clinical Risk
- Vol. 14 (1) , 14-17
Intraoperative cell salvage in obstetrics
Cell salvage is widely used in many surgical specialties to reduce the use of allogeneic blood, which is associated with well-recognized significant complications such as incorrect transfusion, acute and delayed immunological transfusion reactions and transfusion-transmitted infection. Theoretical concerns over the use of cell salvage in obstetrics have focused on the risk of Rhesus immunization and the risk of contamination of the cell-saved blood with traces of amniotic fluid. This article examines the in vitro and in vivo evidence for the safety of the technique, presents current usage figures from Wales and the entire UK, and discusses the current perception of amniotic fluid embolus as an anaphylactoid reaction. It suggests that patients will have to choose between the risks of allogeneic or cell-saved blood, and concludes that the balance of evidence is now in favour of cell salvage in obstetrics.
- 1 January 2008
- Published by SAGE Publications in Clinical Risk
- Vol. 14 (1) , 14-17
Intraoperative cell salvage in obstetrics
Cell salvage is widely used in many surgical specialties to reduce the use of allogeneic blood, which is associated with well-recognized significant complications such as incorrect transfusion, acute and delayed immunological transfusion reactions and transfusion-transmitted infection. Theoretical concerns over the use of cell salvage in obstetrics have focused on the risk of Rhesus immunization and the risk of contamination of the cell-saved blood with traces of amniotic fluid. This article examines the in vitro and in vivo evidence for the safety of the technique, presents current usage figures from Wales and the entire UK, and discusses the current perception of amniotic fluid embolus as an anaphylactoid reaction. It suggests that patients will have to choose between the risks of allogeneic or cell-saved blood, and concludes that the balance of evidence is now in favour of cell salvage in obstetrics.
- 1 July 2007
- Published by Elsevier in International Journal of Obstetric Anesthesia
- Vol. 16 (3) , 241-249
Blood conservation techniques in obstetrics: a UK perspective
- 1 July 2007
- Published by Elsevier in International Journal of Obstetric Anesthesia
- Vol. 16 (3) , 241-249
Blood conservation techniques in obstetrics: a UK perspective